Chemical Structure : BCI-215
CAS No.: 1245792-67-9
货号: PC-60691Not For Human Use, Lab Use Only.
BCI-215 (BCI215) is a potent, tumor cell-selective dual specificity MAPK phosphatase (DUSP-MKP) inhibitor.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥980 | In stock | |
10 mg | ¥1480 | In stock | |
25 mg | ¥2580 | In stock | |
50 mg | ¥4280 | In stock | |
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
BCI-215 (BCI215) is a potent, tumor cell-selective dual specificity MAPK phosphatase (DUSP-MKP) inhibitor.
BCI-215 restores defective MAPK activity caused by overexpression of DUSP1 and DUSP6 in mammalian cells.
BCI-215 inhibits cell motility, causes apoptosis but not primary necrosis, and sensitizes cells to lymphokine-activated killer cell activity in MDA-MB-231 human breast cancer cells.
BCI-215 induces rapid and sustained phosphorylation of ERK, p38 and JNK, also hyperactivates MKK4/SEK1.
BCI-215 causes selective cancer cell cytotoxicity in part through non-redox-mediated activation of MAPK signaling.
分子量 | 396.328 | |
分子式 | C22H22BrNO | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
(E)-2-benzylidene-5-bromo-3-(cyclohexylamino)-2,3-dihydro-1H-inden-1-one |
1. Kaltenmeier CT, et al. J Pharmacol Exp Ther. 2017 Apr;361(1):39-50.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright